Yüklüyor......
NERVE GROWTH FACTOR (NGF) BLOCKADE FOR THE MANAGEMENT OF OSTEOARTHRITIS PAIN: WHAT CAN WE LEARN FROM CLINICAL TRIALS AND PRECLINICAL MODELS?
PURPOSE OF REVIEW: Anti-NGF antibodies hold tremendous potential for the management of osteoarthritis (OA) pain, but clinical trials have revealed serious adverse effects that are incompletely understood. This review discusses clinical trial results along with preclinical studies that have assessed...
Kaydedildi:
| Yayımlandı: | Curr Opin Rheumatol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5436144/ https://ncbi.nlm.nih.gov/pubmed/27672741 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/BOR.0000000000000354 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|